Savara Inc. (SVRA)
NASDAQ: SVRA
· Real-Time Price · USD
3.44
-0.03 (-0.86%)
At close: Sep 26, 2025, 11:06 AM
-0.86% (1D)
| Bid | 2.47 |
| Market Cap | 595.42M |
| Revenue (ttm) | 272K |
| Net Income (ttm) | -110.33M |
| EPS (ttm) | -0.51 |
| PE Ratio (ttm) | -6.75 |
| Forward PE | -7.16 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 4.37 |
| Volume | 128,816 |
| Avg. Volume (20D) | 1,432,934 |
| Open | 3.47 |
| Previous Close | 3.47 |
| Day's Range | 3.37 - 3.48 |
| 52-Week Range | 1.89 - 4.33 |
| Beta | 0.56 |
| Ex-Dividend Date | n/a |
About SVRA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol SVRA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for SVRA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts4 months ago
+9.79%
Savara shares are trading higher. Guggenheim maint...
Unlock content with
Pro Subscription
4 months ago
-31.69%
Savara shares are trading lower after the company announced it received a refusal to file letter from the FDA for its biologics license application.
